Cost-Minimization Analysis of Three Therapeutic Regimens for Children's Bronchopneumonia
- VernacularTitle:3种头孢类抗菌药物治疗儿童支气管肺炎的最小成本分析
- Author:
Xiaoyong WANG
;
Youxiang SONG
- Publication Type:Journal Article
- Keywords:
Children;
Bronchopneumonia;
Therapeutic regimens;
Cost-minimization analysis
- From:
China Pharmacy
2005;0(14):-
- CountryChina
- Language:Chinese
-
Abstract:
0.05)and the total costs of the 3 groups were 1 111.82 yuan,1 132.82 yuan and 1 219.62 yuan,respectively.CONCLUSION:Group A(Ceftriaxone Sodium)has been proved to be preferable for children's bronchopneumonia.